| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |